Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Receivables (2017 - 2025)

Inspire Medical Systems' Change in Receivables history spans 9 years, with the latest figure at $11.6 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 194.61% year-over-year to $11.6 million; the TTM value through Dec 2025 reached $26.2 million, up 908.19%, while the annual FY2025 figure was $26.2 million, 908.19% up from the prior year.
  • Change in Receivables for Q4 2025 was $11.6 million at Inspire Medical Systems, up from -$29.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $44.6 million in Q2 2025 and bottomed at -$29.7 million in Q3 2025.
  • The 5-year median for Change in Receivables is $5.2 million (2022), against an average of $4.8 million.
  • The largest annual shift saw Change in Receivables surged 500.37% in 2021 before it tumbled 1173.47% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $7.5 million in 2021, then skyrocketed by 68.27% to $12.6 million in 2022, then soared by 47.6% to $18.6 million in 2023, then tumbled by 78.8% to $3.9 million in 2024, then surged by 194.61% to $11.6 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Change in Receivables are $11.6 million (Q4 2025), -$29.7 million (Q3 2025), and $44.6 million (Q2 2025).